NCT03745651 · Interventional trial
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Hassman Research Institute · Berlin, NJ · Camden County
First posted
Registry updated
Added to the directory